Psychedelics have been subject to an increasing amount of research in recent years in the wake of widespread drug reform. Although most psychedelic research is still in its infancy, current studies have revealed that hallucinogenic drugs are capable of inducing profound and long-term insights in users with minimal doses.
This makes psychedelics a viable treatment for a variety of mental health disorders, with studies showing that these substances are useful in the treatment and management of symptoms of conditions such as post-traumatic stress disorder, anxiety and treatment-resistant depression.
Researchers have posited that these benefits are derived from the fact that psychedelics can help change how users see themselves and the world around them. This, in turn, makes it easier for them to break through maladaptive thought patterns and develop healthier ones instead.
New research now shows that psilocybin, the main psychoactive agent in “magic mushrooms,” may deliver some of its benefits by helping users create strong ties with nature. The research suggests that compared to other psychedelics, psilocybin affects how users see the natural world and create a stronger connection with nature.
Previous research had already shown that classic psychedelics such as psilocybin and LSD increased people’s connectedness with nature and even made them more interested in issues regarding the environment and climate change.
However, the majority of these studies did not take into account the different subjective effects of different classic psychedelics. Classic psychedelics are a type of hallucinogens that profoundly alter users’ thoughts, emotions and perceptions by acting on the brain’s serotonin system.
The researchers behind the recent study wanted to determine whether all classic psychedelics or just a few specific ones are capable of boosting nature-relatedness. Sam Gandy, one of the investigators, stated that his interest in the matter was piqued in 2015 when study coauthor David Luke presented a paper investigating the effects of different psychedelics on people’s ecological concern and nature connectedness at a psychedelic conference.
Gandy sought to collaborate with Luke to determine the specific impact of different classic psychedelics on people’s connection to nature. For their study, the investigators reviewed data from five previous studies that had analyzed the relationship between nature-relatedness and different psychedelics and found that only psilocybin use was a reliable predictor of increased nature-relatedness.
Gandy explained that on top of increasing nature-relatedness in users, psilocybin was also associated with users’ sense of self and identity in relation to nature, their value and attitudes toward nature, as well as their personal experience with nature.
Study coauthor Matthias Forstmann concluded that more experience with psilocybin predicted more nature-relatedness, in comparison to other psychedelic substances.
Many entities, such as Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF), are focusing on a number of hallucinogenic substances, and a lot more information is likely to emerge regarding the numerous medicinal uses that these compounds can have.
NOTE TO INVESTORS: The latest news and updates relating to Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) are available in the company’s newsroom at https://ibn.fm/DELCF
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.psychedelicnewswire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
